Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease
- 15 August 1996
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 78 (4), 409-414
- https://doi.org/10.1016/s0002-9149(96)00328-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of posthospital survival after acute myocardial infarction in women and menThe American Journal of Cardiology, 1994
- Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)The American Journal of Cardiology, 1993
- A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.Circulation, 1993
- A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United StatesNew England Journal of Medicine, 1993
- Pravastatin, lipids, and atherosclerosis in the carotid arteries: Design features of a clinical trial with carotid atherosclerosis outcomeControlled Clinical Trials, 1992
- Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysisJournal of the American College of Cardiology, 1991
- Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart DiseaseJAMA, 1991
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- Long survival following myocardial infarctionThe American Journal of Cardiology, 1962